Bernhard Leslie

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
16
Insider Sells Sum
$615,910.65

Insider Activity of Bernhard Leslie

According to the SEC Form 4 filings, Bernhard Leslie, being in a position of

  1. director at Sachem Capital Corp.,
    оver the last 12 months, has bought 0 shares, and sold 4650 shares for $16,680,
    over all time since 2022-08-12, has bought 0 shares, and sold 7125 shares for $26,653.

The largest sale of all time was on 2010-09-28 and amounted to 169566 shares of Milestone Scientific Inc. for $162,393.

Biography of Bernhard Leslie

No biography is available at this moment.

2023-11-22SaleSachem Capital Corp.
SACH
director
2,750
0.006%
$3.58$9,859-10.25%
2023-11-15SaleSachem Capital Corp.
SACH
director
1,900
0.0042%
$3.59$6,821-8.99%
2022-12-19SaleMilestone Scientific Inc.
MLSS
director
79,268
0.1081%
$0.50$39,634+69.23%
2022-11-23SaleMilestone Scientific Inc.
MLSS
director
14,358
0.0227%
$0.64$9,189+54.39%
2022-11-11SaleSachem Capital Corp.
SACH
director
1,850
0.0049%
$3.74$6,921+0.06%
2022-08-12SaleSachem Capital Corp.
SACH
625
0.0016%
$4.88$3,052-21.38%
2022-04-05SaleMilestone Scientific Inc.
MLSS
1,256
0.0018%
$1.37$1,721-39.42%
2021-09-17SaleMilestone Scientific Inc.
MLSS
director
7,938
0.0109%
$1.92$15,265-37.31%
2021-09-16SaleMilestone Scientific Inc.
MLSS
director
27,062
0.0398%
$1.89$51,246-31.89%
2021-09-15SaleMilestone Scientific Inc.
MLSS
director
10,000
0.0142%
$1.93$19,260-35.13%
2021-02-17SaleMilestone Scientific Inc.
MLSS
director
20,000
0.0294%
$3.61$72,200-43.36%
2021-02-16SaleMilestone Scientific Inc.
MLSS
director
25,000
0.0375%
$3.87$96,750-46.13%
2012-06-27SaleMilestone Scientific Inc.
MLSS
director
103,448
0.4173%
$0.29$30,000+137.78%
2011-06-21SaleMilestone Scientific Inc.
MLSS
director
50,000
0.3269%
$0.60$30,000-18.03%
2010-09-28SaleMilestone Scientific Inc.
MLSS
director
169,566
1.1501%
$0.96$162,393-21.05%
2007-07-13SaleMilestone Scientific Inc.
MLSS
director
40,000
0.2079%
$1.54$61,600-33.88%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.